Status:

NOT_YET_RECRUITING

Effect of Dry Needling Plus Vibration on Myofascial Trigger Points in Individuals With Nonspecific Low Back Pain

Lead Sponsor:

Universidad de Zaragoza

Conditions:

Low Back Pain

Dry Needling

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Low back pain is one of the most common health issues worldwide, and in most cases, this pain is nonspecific low back pain (NSLBP). NSLBP is characterized by the inability to determine the real source...

Detailed Description

This study aims to evaluate the efficacy of a new invasive therapy for treating MTrPs: dry needling with vibratory stimulus (DN+V). The following hypotheses are proposed: * DN+V will utilize vibratio...

Eligibility Criteria

Inclusion

  • Individuals with nonspecific low back pain, defined as pain persisting for more than 3 months between the twelfth rib and the buttocks, registering a Numeric Pain Rating Scale (NPRS) score of 3 or higher prior to the intervention. Additionally, participants must meet the following criteria:
  • Presence of myofascial trigger points (PGMs) in any of the following muscles relevant to the project: erector spinae (longissimus and iliocostal), multifidus, gluteus maximus, gluteus medius, and quadratus lumborum. Detection of these PGMs will be conducted by a specialized physiotherapist.
  • Individuals aged 18 years or older, proficient in either Spanish or English. Participants who have provided informed consent by signing the consent form

Exclusion

  • Diagnosis of lumbar pain associated with specific pathologies such as disc herniations or neurological disorders.
  • Recent infiltration therapy within the past 3 months.
  • Recent manual therapy, acupuncture, or dry needling interventions in the lumbopelvic region within the last 4 weeks.
  • Previous surgical intervention in the lumbopelvic region.
  • Leg length discrepancy (\>1 cm).
  • Recent use of anticoagulant or antiplatelet medications within the last week.
  • Systemic or local infection in the lumbar region.
  • Pregnancy.
  • Needle phobia (belonephobia).

Key Trial Info

Start Date :

May 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT06527339

Start Date

May 1 2026

End Date

December 1 2026

Last Update

December 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universidad de Zaragoza

Zaragoza, Zaragoza, Spain, 50009